首页|中晚期宫颈癌患者血清HE4、TK1、DCLK1水平变化及其与化疗效果的关系

中晚期宫颈癌患者血清HE4、TK1、DCLK1水平变化及其与化疗效果的关系

扫码查看
目的 分析中晚期宫颈癌患者血清人附睾蛋白4(HE4)、胸苷激酶1(TK1)、双皮质素样激酶1(DCLK1)变化及其与化疗效果的关系.方法 收集2020年1月至2023年1月于郑州大学第一附属医院接受化疗的215例中晚期宫颈癌患者的病历资料,根据纳入患者的化疗效果将其分为良好组和不良组,其中良好组疗效评估结果为完全缓解(CR)与部分缓解(PR),共173例,不良组疗效评估结果为稳定(SD)与进展(PD),共42例.比较两组血清HE4、TK1、DCLK1水平等临床资料,分析中晚期宫颈癌患者血清HE4、TK1、DCLK1水平与化疗效果的关系.结果 良好组临床分期为Ⅱ期比例、高分化比例、无淋巴结转移比例均高于不良组,肿瘤最大直径以及血清HE4、TK1、DCLK1水平均低于不良组,差异均有统计学意义(P<0.05);经logistic多因素分析显示,肿瘤的临床分期达到Ⅳ期、分化程度为中低分化、淋巴结转移以及血清HE4、TK1、DCLK1水平升高均为影响中晚期宫颈癌患者化疗效果的独立因素(P<0.05);经Spearman相关性分析显示,中晚期宫颈癌患者临床分期、淋巴结转移以及血清HE4、TK1、DCLK1水平与其化疗效果成负相关,分化程度与其化疗效果成正相关(P<0.05).结论 中晚期宫颈癌患者临床分期越晚、分化程度越差、临床转移以及HE4、TK1、DCLK1水平越高,越不利于患者的化疗,上述指标对其预后均具有一定预测价值.
Changes of serum levels of human epididymal protein 4, thymidine kinase 1 and bifocorticoid kinase 1 in patients with advanced cervical cancer and their relationship with chemotherapy
Objective To analyze the changes in serum human epididymis protein 4(HE4),thy-midine kinase 1(TK1)and doublecortin-like kinase protein 1(DCLK1)in patients with advanced cervical cancer and their relationship with the effect of chemotherapy. Methods The medical records of 215 patients with advanced cervical cancer who received chemotherapy in the hospital from January 2020 to January 2023 were collected retrospectively. The enrolled patients were divided into two groupd based on the effect of chemo-therapy:a good group consisting of 173 patients with complete remission(CR)and partial remission(PR) and a poor group with 42 patients showing stable disease(SD)and progressive disease(PD). Serum levels of HE4,TK1 and DCLK1 in the two groups were compared. The study aimed to analyze the relationship between serum levels of HE4,TK1 and DCLK1 and the effectiveness of chemotherapy in patients with advanced cervi-cal cancer. Results The proportions of clinical stageⅡ,high differentiation,and no lymph node metastasis in the good group were higher than those in the poor group. The maximum tumor diameter ,serum levels of HE4,TK1 and DCLK1 were lower in the good group compasred to the poor group(P<0.05). Logistic multi-variate analysis revealed that the tumor reaching stageⅣ,moderate to low differentiation,lymph node metas-tasis,and elevated levels of serum HE4,TK1,and DCLK1 were independent factors affecting chemotherapy efficacy in patients with advanced cervical cancer(P<0.05). Spearman correlation analysis showed that clini-cal staging,lymph node metastasis,and serum levels of HE4,TK1 and DCLK1 were negatively correlated with chemotherapy effectiveness in patients with advanced cervical cancer ,while differentiation degree was positively correlated with chemotherapy effectiveness(P<0.05). Conclusion The later the clinical stage,the worse the differentiation,the higher the clinical metastasis,and the higher the levels of HE4,TK1,and DCLK1 in patients with advanced cervical cancer,the more unfavorable chemotherapy is for the patient. These indicators have a certain predictive value for their prognosis

Advanced cervical cancerHuman epididymis protein 4Thymidine kinase 1Doublecortin-like kinase protein 1

张艳艳、苏克、乔龙、郭瑞霞

展开 >

郑州大学第一附属医院妇科,河南,郑州450000

中晚期宫颈癌 人附睾蛋白4 胸苷激酶1 双皮质素样激酶1

河南省医学科技攻关计划(联合共建项目)

LHGJ20190115

2024

分子诊断与治疗杂志
中山大学

分子诊断与治疗杂志

CSTPCD
影响因子:0.65
ISSN:1674-6929
年,卷(期):2024.16(3)
  • 15